Business

Announcement on the Approval of Voluntary Disclosure of Clinical Trial Application for Freeze-dried Haemophilus Influenzae Type b Conjugate Vaccine

Announcement on the Approval of Voluntary Disclosure of Clinical Trial Application for Freeze-dried Haemophilus Influenzae Type b Conjugate Vaccine

articleChangchun Bcht Biotechnology Co. Class ADecember 25, 20243/news/announcement-on-the-approval-of-voluntary-disclosure-of-clinical-trial-application-for-freeze-dried-haemophilus-influenzae-type-b-conjugate-vaccine
Announcement on the Approval of Voluntary Disclosure of Clinical Trial Application for Freeze-dried Haemophilus Influenzae Type b Conjugate Vaccine

About this update from Changchun Bcht Biotechnology Co. Class A

Announcement on the Approval of Voluntary Disclosure of Clinical Trial Application for Freeze-dried Haemophilus Influenzae Type b Conjugate Vaccine The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Changchun Bcht Biotechnology Co. Class A